Overview
Congenital tuberculosis (TB) occurs when Mycobacterium tuberculosis is transmitted from an infected mother to the fetus or neonate, often presenting with severe systemic involvement including respiratory distress, hepatosplenomegaly, and multiorgan failure 1. It represents a small but critical subset of TB cases, particularly in endemic regions 1.Diagnosis
Clinical Presentation: Respiratory distress, hepatosplenomegaly, abnormal coagulation profiles, and signs of multiorgan failure 1.
Diagnostic Tests:
- Tuberculin skin test (TST) or interferon-gamma release assays (IGRAs) may be positive but are not definitive in neonates 1.
- TB PCR and culture: Confirmatory tests, though results can be delayed 1.
- Maternal chest imaging: Reveals miliary TB patterns when suspected 1.
Challenges: Overlapping symptoms with bacterial sepsis, viral infections, and immunodeficiency complicate early diagnosis 1.Management
First-Line Treatment:
- Isoniazid (INH): Typically initiated at standard neonatal doses 1.
- Rifampin (RIF): Added to INH for multidrug-resistant cases, though standard neonatal dosing varies 1.
- Ethambutol (EMB): Used in combination therapy, dose adjusted for neonates 1.
- Pyrazinamide (PZA): Considered in severe cases or for rapid response, dose adjusted 1.
Adjunctive Measures: Supportive care including respiratory support, management of coagulopathy, and monitoring for multiorgan dysfunction 1.Special Populations
Pediatrics: Neonates are particularly vulnerable, requiring early suspicion and prompt initiation of treatment to prevent severe outcomes 1.
Maternal Considerations: Postnatal diagnosis often prompts maternal evaluation and treatment for latent or active TB 1.Key Recommendations
Suspect congenital TB in neonates with respiratory distress and systemic symptoms in TB-endemic regions (Evidence: Moderate 1).
Initiate empirical anti-TB therapy promptly in neonates with suspected congenital TB while awaiting confirmatory test results (Evidence: Expert opinion 1).
Conduct thorough maternal evaluation for TB following neonatal diagnosis, even in the absence of maternal symptoms (Evidence: Moderate 1).References
1 Ranganath B, Selvan M, Chaudhari K, Devi U. Challenges in diagnosing disseminated congenital tuberculosis in a neonate: outcome and maternal treatment opportunity. BMJ case reports 2024. link